Literature DB >> 27403379

The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.

Recep Bedir1, Hasan Güçer1, İbrahim Şehitoğlu1, Cüneyt Yurdakul1, Pelin Bağcı2, Pelin Üstüner3.   

Abstract

BACKGROUND: Distinguishing squamous cell carcinoma (SCC) from keratoacanthoma (KA) by histopathological features may not be sufficient for a differential diagnosis, as KAs may, in some cases, imitate well-differentiated SCCs. AIMS: In this study, we investigated whether the expression of the p16, p21, p27, p53 genes and a Ki-67 proliferation index are useful in distinguishing between these two tumors. STUDY
DESIGN: Cross-sectional study.
METHODS: Immunohistochemistry was used to investigate the expression of the p16, p21, p27, p53 genes and the Ki-67 proliferation index was investigated in well-differentiated SCC with KA-like features (n=40) and KA (n=30).
RESULTS: The results of all of the examined markers, except for p27 (p16, p21, p53, and Ki-67) were found to be significantly different between the SCC and KA samples (p<0.05).
CONCLUSION: In well-differentiated SCC with KA-like features and KA cases where the differential diagnosis is difficult from a histopathological perspective, the use of p16, p21, p53 expression and a Ki-67 proliferation index can be useful for the differential diagnosis of SCCs and KAs.

Entities:  

Keywords:  Differential diagnosis; immunohistochemistry; keratoacanthoma; skin; squamous cell carcinoma

Year:  2016        PMID: 27403379      PMCID: PMC4924954          DOI: 10.5152/balkanmedj.2016.16442

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  31 in total

1.  Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.

Authors:  B Cribier; P Asch; E Grosshans
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

Review 2.  Keratoacanthoma: a tumor in search of a classification.

Authors:  Amel Karaa; Amor Khachemoune
Journal:  Int J Dermatol       Date:  2007-07       Impact factor: 2.736

3.  Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma.

Authors:  W Hu; T Cook; C W Oh; N S Penneys
Journal:  J Am Acad Dermatol       Date:  2000-03       Impact factor: 11.527

4.  Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.

Authors:  Tanja Batinac; Gordana Zamolo; Miran Coklo; Ita Hadzisejdic; Christophe Stemberger; Gordana Zauhar
Journal:  Pathol Res Pract       Date:  2006-06-15       Impact factor: 3.250

5.  Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.

Authors:  Tiina T Kuivanen; Leila Jeskanen; Lauri Kyllönen; Ulla Impola; Ulpu K Saarialho-Kere
Journal:  Mod Pathol       Date:  2006-05-12       Impact factor: 7.842

6.  Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.

Authors:  Thomas C Putti; Ming Teh; Yoke S Lee
Journal:  Mod Pathol       Date:  2004-04       Impact factor: 7.842

7.  Keratoacanthoma. A clinical study.

Authors:  J Kingman; J P Callen
Journal:  Arch Dermatol       Date:  1984-06

8.  Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.

Authors:  T Ho; T Horn; E Finzi
Journal:  Arch Dermatol       Date:  1991-08

9.  Quantitative image analysis of p53 protein accumulation in keratoacanthomas.

Authors:  A Borkowski; W P Bennett; R T Jones; P Borkowski; C C Harris; L R Ferreira; G F Kao; B F Trump
Journal:  Am J Dermatopathol       Date:  1995-08       Impact factor: 1.533

10.  The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.

Authors:  Natasa Vasiljević; Kristin Andersson; Kaj Bjelkenkrantz; Christer Kjellström; Henrik Månsson; Elise Nilsson; Goran Landberg; Joakim Dillner; Ola Forslund
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

View more
  5 in total

1.  Chrysotile effects on the expression of anti-oncogene P53 and P16 and oncogene C-jun and C-fos in Wistar rats' lung tissues.

Authors:  Yan Cui; Yuchan Wang; Jianjun Deng; Gongli Hu; Faqin Dong; Qingbi Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-13       Impact factor: 4.223

2.  Squamous cell carcinoma in a digit of the hind limb with systemic metastasis in a 17-year-old female koala.

Authors:  Mio Kobayashi; Toshinori Yoshida; Risako Yamashita; Rho Ichikawa; Junta Nakahara; Kazuki Nakamura; Hiromu Okano; Yasunori Takahashi; Nanao Ito; Makoto Shibutani
Journal:  J Vet Med Sci       Date:  2021-04-26       Impact factor: 1.267

3.  Recombinant SjP40 protein enhances p27 promoter expression in hepatic stellate cells via an E2F1-dependent mechanism.

Authors:  Yinong Duan; Lei Lyu; Dandan Zhu; Jianxin Wang; Jinling Chen; Liuting Chen; Chunzhao Yang; Xiaolei Sun
Journal:  Oncotarget       Date:  2017-06-20

4.  Expression of FOXC2, PinX1, Ki-67 and Cyclin D1 in cutaneous cell carcinoma.

Authors:  Haiying Zhao; Yunfeng Cao; Guoqiang Wang; Zengxiang Luo
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

5.  Intestinal stem cells acquire premature senescence and senescence associated secretory phenotype concurrent with persistent DNA damage after heavy ion radiation in mice.

Authors:  Santosh Kumar; Shubhankar Suman; Albert J Fornace; Kamal Datta
Journal:  Aging (Albany NY)       Date:  2019-06-25       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.